Resolution of MRI findings of copper deficiency myeloneuropathy in a patient with Wilson?s disease

Silva‐Júnior, Francisco Pereira da; Machado, A. A.; Lucato, Leandro Tavares; Barbosa, Egberto Reis

doi:10.1590/0004-282x20130226

Cited by 3 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients in whom excess zinc ingestion is the cause, stopping zinc supplements may suffice and no additional copper supplements may be required. 1,15,18 Vitamin E Deficiency…”

Section: 16mentioning

confidence: 99%

Toxic and Metabolic Myelopathies

Ramalho

Nunes

Rocha

et al. 2016

Seminars in Ultrasound, CT and MRI

View full text Add to dashboard Cite

Myelopathy describes any neurologic deficit related to the spinal cord. It is most commonly caused by its compression by neoplasms, degenerative disc disease, trauma, or infection. Less common causes of myelopathy include spinal cord tumors, infection, inflammatory, neurodegenerative, vascular, toxic, and metabolic disorders. Conditions affecting the spinal cord must be recognized as early as possible to prevent progression that may lead to permanent disability. Biopsy is rarely performed, thus the diagnosis and management rely on patient's history, physical examination, laboratory results, and imaging findings. Here we review the clinical presentations, pathophysiological mechanisms, and magnetic resonance imaging findings of myelopathies related to metabolic or toxic etiologies. Semin Ultrasound CT MRI 37:448-465 C 2016 Elsevier Inc. All rights reserved.

show abstract

“…In patients in whom excess zinc ingestion is the cause, stopping zinc supplements may suffice and no additional copper supplements may be required. 1,15,18 Vitamin E Deficiency…”

Section: 16mentioning

confidence: 99%

Toxic and Metabolic Myelopathies

Ramalho

Nunes

Rocha

et al. 2016

Seminars in Ultrasound, CT and MRI

View full text Add to dashboard Cite

show abstract

Clinical efficacy and safety of Gandouling plus low-dose D-penicillamine for treatment of Wilson's disease with neurological symptoms

Zhang

Chen

et al. 2018

Journal of Traditional Chinese Medicine

View full text Add to dashboard Cite

Spinal Cord Involvement in Pediatric-Onset Metabolic Disorders With Mendelian and Mitochondrial Inheritance

et al. 2021

View full text Add to dashboard Cite

Previous reviews have described the features of brain involvement in pediatric-onset metabolic disorders with Mendelian and mitochondrial inheritance, but only a few have focused on spinal cord abnormalities. An increasing number of metabolic disorders with Mendelian and mitochondrial inheritance in children with predominant spinal cord involvement has been recognized. Spinal cord involvement may be isolated or may occur more frequently with brain involvement. Timely diagnosis and occasional genetic counseling are needed for timely therapy. Therefore, clinicians must be aware of the clinical, laboratory, and radiographic features of these disorders. In this review, we describe pediatric-onset metabolic disorders with Mendelian and mitochondrial inheritance and predominant spinal cord involvement. Furthermore, we provide an overview of these conditions, including background information and examples that require rapid identification, focusing on treatable conditions; that would be catastrophic if they are not recognized.

show abstract

Resolution of MRI findings of copper deficiency myeloneuropathy in a patient with Wilson?s disease

Cited by 3 publications

References 2 publications

Toxic and Metabolic Myelopathies

Toxic and Metabolic Myelopathies

Clinical efficacy and safety of Gandouling plus low-dose D-penicillamine for treatment of Wilson's disease with neurological symptoms

Spinal Cord Involvement in Pediatric-Onset Metabolic Disorders With Mendelian and Mitochondrial Inheritance

Contact Info

Product

Resources

About